Please Note

The Washington Post is providing this important information about the coronavirus for free. For more free coverage of the coronavirus pandemic, sign up for our Coronavirus Updates newsletter where all stories are free to read.

Federal regulators are forcing Johnson & Johnson to scrap about 60 million doses of the coronavirus vaccine made at the problem-plagued Emergent BioSolutions plant after possible contamination, according to an individual familiar with the situation.

The Food and Drug Administration, which found unsanitary conditions in an inspection of the plant in April, cleared 10 million doses made at the facility for use. Those salvaged doses are expected to be sent overseas as part of President Biden’s effort to share vaccines with other nations.

The plant fell under federal scrutiny after a discovery in March that a batch of Johnson & Johnson’s vaccine was contaminated with a key ingredient used to produce AstraZeneca’s.

The 60 million doses that must be discarded are in addition to the 15 million already thrown out that were contaminated by the AstraZeneca vaccine at the plant this year.

Here are some significant developments:

  • Federal regulators have approved and extended the shelf life of the Johnson & Johnson coronavirus vaccine by six weeks, shortly before millions of doses reach their expiration dates.
  • With coronavirus vaccines available to adolescents and adults, regulators are now turning their attention to possibly authorizing shots for children as young as 6 months.
  • The United States will provide half a billion vaccines to the world starting in the summer — the largest vaccine donation in history — as part of the G-7′s effort to end the pandemic by 2022.
  • The United States on Thursday reported a seven-day rolling average of 15,692 new infections. Since Dec. 14, more than 305 million doses of coronavirus vaccine have been administered in the United States.